Press Release Year: 2010

Plaintiffs and Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, Agree to Resolve All Gender Discrimination Claims Associated With Class Action

July 14th, 2010

Plaintiffs and Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, agree to resolve all gender discrimination claims associated with class action Agreement reached between Novartis Pharmaceuticals Corporation (NPC) and Class Plaintiffs – company to make monetary payment of up to USD 152.5 million to eligible class members As part of its commitment to fostering […]

Read More

Novartis Class Awarded $250 Million in Punitive Damages

May 19th, 2010

Verdict Is Strong Rebuke to Pharma Giant’s Gender Discrimination. Sparks Hope for Change in Company’s Treatment of Female Sales Reps For more information, contact Jamie Moss, newPRos, 201-493-1027; jamie@newspros.com (May 19, 2010, New York City) –After delivering a unanimous verdict against Novartis on all counts and awarding 12 former Novartis sales reps $3.36 million in […]

Read More

Female Sales Reps Win Case Against Novartis in Largest Gender Discrimination Case to go to Verdict

May 17th, 2010

Jury Says Pharma Giant Discriminated Against Women Will Decide Punitive Damages Tomorrow  For more information, contact Jamie Moss, newPRos, 201-493-1027; jamie@newspros.com (May 17, 2010, New York City) – A New York jury handed Novartis Pharmaceuticals a bitter pill today, finding the giant drug maker guilty of gender discrimination in pay, promotional opportunities and pregnancy-related matters.  […]

Read More

Novartis Gender Discrimination Trial Begins Today

April 7th, 2010

5600 Female Employees Seek $200M for Disparities in Pay and Promotion & Pregnancy Discrimination For more information, contact Jamie Moss, 201-493-1027 (April 7, 2010, New York) — Jury selection begins today in what is believed to be one of the largest gender discrimination class actions ever to go to trial in the U.S. Over 5600 […]

Read More

Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation

March 11th, 2010

Physicians and Hospitals Get Kickbacks and Other Incentives Manufacturers Promoting Off-Label, Unapproved Cardiac Surgery Using Their Devices For more information, contact Jaime Baum, 847 502 3825, JBaumPR@gmail.com (March 11, 2010, Washington, D.C.) – As reported in today’s Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the […]

Read More
Back to Top